| Project/Area Number |
22791140
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Psychiatric science
|
|---|
| Research Institution | Keio University |
|---|
Principal Investigator |
|
|---|
| Research Collaborator |
BIES Robert R. Indiana University School of Medicine, Division of Clinical Pharmacology, 准教授
MAMO David University of Toronto, Department of Psychiatry, 准教授
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2011: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2010: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Keywords | 血中濃度 / 抗精神病薬 / 統合失調症 / 血中動態 / ドパミン / 予測 |
|---|
| Research Abstract |
The present study, including50patients with schizophrenia, demonstrated that antipsychotic plasma concentrations of risperidone and its active moiety can be predicted before performing an actual dosage change, using population pharmacokinetic techniques. These findings suggest that individualized dosing with the measurement of antipsychotic plasma concentrations could become a real clinical application in the management of schizophrenia.
|
